These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20230536)

  • 1. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant CJD and blood transfusion: are there additional cases?
    Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
    Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
    Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
    Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
    Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prions and transfusion medicine.
    Budka H
    Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.
    Checchi M; Hewitt PE; Bennett P; Ward HJ; Will RG; Mackenzie JM; Sinka K
    Vox Sang; 2016 Nov; 111(4):325-332. PubMed ID: 27432362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.
    Gillies M; Chohan G; Llewelyn CA; MacKenzie J; Ward HJ; Hewitt PE; Will RG
    Vox Sang; 2009 Oct; 97(3):211-8. PubMed ID: 19671123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of vCJD on blood supply.
    Seitz R; von Auer F; Blümel J; Burger R; Buschmann A; Dietz K; Heiden M; Hitzler WE; Klamm H; Kreil T; Kretzschmar H; Nübling M; Offergeld R; Pauli G; Schottstedt V; Volkers P; Zerr I
    Biologicals; 2007 Apr; 35(2):79-97. PubMed ID: 17320412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood.
    Gregori L; Yang H; Anderson S
    Transfusion; 2011 Dec; 51(12):2596-602. PubMed ID: 21645006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments.
    Hunter N; Houston F
    Dev Biol (Basel); 2002; 108():93-8. PubMed ID: 12220147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
    van Aken WG
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1444-7. PubMed ID: 11503311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to reduce transfusion acquired vCJD.
    Wallis JP
    Transfus Med; 2011 Feb; 21(1):1-6. PubMed ID: 21070399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
    Teljeur C; Flattery M; Harrington P; O'Neill M; Moran PS; Murphy L; Ryan M
    Transfusion; 2012 Nov; 52(11):2285-93. PubMed ID: 22486387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.